Organon: Q4 Earnings Snapshot

February 17, 2022 GMT

JERSEY CITY, N.J. (AP) _ Organon & Co. (OGN) on Thursday reported fourth-quarter earnings of $202 million.

On a per-share basis, the Jersey City, New Jersey-based company said it had profit of 79 cents. Earnings, adjusted for non-recurring costs, were $1.37 per share.

The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.25 per share.

The pharmaceutical company posted revenue of $1.6 billion in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $1.58 billion.

For the year, the company reported profit of $1.35 billion, or $5.31 per share. Revenue was reported as $6.3 billion.

Organon expects full-year revenue in the range of $6.1 billion to $6.4 billion.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on OGN at